Correction to: High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin lymphoma

A Correction to this paper has been published:https://doi.org/10.1007/s00277-021-04503-1
Source: Annals of Hematology - Category: Hematology Source Type: research